GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.

Have any questions? Please email us at ecoliwiki@gmail.com

PMID:20660724

From GONUTS
Jump to: navigation, search
Citation

Lipinski, MM, Zheng, B, Lu, T, Yan, Z, Py, BF, Ng, A, Xavier, RJ, Li, C, Yankner, BA, Scherzer, CR and Yuan, J (2010) Genome-wide analysis reveals mechanisms modulating autophagy in normal brain aging and in Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 107:14164-9

Abstract

Dysregulation of autophagy, a cellular catabolic mechanism essential for degradation of misfolded proteins, has been implicated in multiple neurodegenerative diseases. However, the mechanisms that lead to the autophagy dysfunction are still not clear. Based on the results of a genome-wide screen, we show that reactive oxygen species (ROS) serve as common mediators upstream of the activation of the type III PI3 kinase, which is critical for the initiation of autophagy. Furthermore, ROS play an essential function in the induction of the type III PI3 kinase and autophagy in response to amyloid beta peptide, the main pathogenic mediator of Alzheimer's disease (AD). However, lysosomal blockage also caused by Abeta is independent of ROS. In addition, we demonstrate that autophagy is transcriptionally down-regulated during normal aging in the human brain. Strikingly, in contrast to normal aging, we observe transcriptional up-regulation of autophagy in the brains of AD patients, suggesting that there might be a compensatory regulation of autophagy. Interestingly, we show that an AD drug and an AD drug candidate have inhibitory effects on autophagy, raising the possibility that decreasing input into the lysosomal system may help to reduce cellular stress in AD. Finally, we provide a list of candidate drug targets that can be used to safely modulate levels of autophagy without causing cell death.

Links

PubMed PMC2922576 Online version:10.1073/pnas.1009485107

Keywords

Aging/genetics; Alzheimer Disease/genetics; Alzheimer Disease/pathology; Amyloid beta-Peptides/metabolism; Autophagy/genetics; Brain/pathology; Brain/physiology; Gene Expression Regulation; Genome-Wide Association Study; Humans; Lysosomes/metabolism; Phosphatidylinositol 3-Kinases/metabolism; Reactive Oxygen Species/metabolism

Significance

Annotations

Gene product Qualifier GO Term Evidence Code with/from Aspect Extension Notes Status

HUMAN:BCL2

GO:0004676: 3-phosphoinositide-dependent protein kinase activity

ECO:0000315:

F

In Fig 1 b and 1 c screen was conducted that showed that the overexpression of Bcl-2 leads to decrease in levels of autophagy and type III P13 kinase. Screen showed that there was an increase in cell viability and decrease in levels of PtdIns3P following knock down of the hit genes in H4 cells expressing Bcl-2 compared to WT controls

complete

HUMAN:COX5A

GO:2000378: negative regulation of reactive oxygen species metabolic process

ECO:0000315:

P

Figure 3a displays how the knock down of Cox5a led to accumulation of reactive oxygen species in H4 cells.

complete
CACAO 11839

HUMAN:COX5A

GO:0010507: negative regulation of autophagy

ECO:0000315:

P

Figure 3b displays how the knock down of Cox5a resulted in the induction of autophagy in cells transfected with siRNAs against Cox5a or controls. The autophagy levels were then tested with antibodies against p62m Atg5 (Atg12-Atg5 complex) and LC3.

complete
CACAO 11842

Notes

See also

References

See Help:References for how to manage references in GONUTS.